Zeltiq Aesthetics Inc. (NASDAQ:ZLTQ) had its target price increased by Stifel Nicolaus from $38.00 to $52.00 in a research note issued on Wednesday. The firm currently has a “buy” rating on the stock. Stifel Nicolaus’ price objective suggests a potential upside of 33.44% from the company’s current price.

Other equities research analysts also recently issued research reports about the stock. Leerink Swann restated a “buy” rating on shares of Zeltiq Aesthetics in a research report on Thursday, June 30th. Brean Capital restated a “buy” rating and issued a $35.00 price objective on shares of Zeltiq Aesthetics in a research report on Tuesday, June 21st. Maxim Group raised their price objective on shares of Zeltiq Aesthetics from $40.00 to $48.00 and gave the company a “buy” rating in a research report on Tuesday, August 9th. Zacks Investment Research upgraded shares of Zeltiq Aesthetics from a “sell” rating to a “hold” rating in a research report on Saturday, July 23rd. Finally, TheStreet cut shares of Zeltiq Aesthetics from a “buy” rating to a “hold” rating in a report on Friday, June 10th. Three research analysts have rated the stock with a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average target price of $39.89.

Analyst Recommendations for Zeltiq Aesthetics (NASDAQ:ZLTQ)

Zeltiq Aesthetics (NASDAQ:ZLTQ) opened at 38.97 on Wednesday. The firm has a market capitalization of $1.54 billion, a PE ratio of 58.60 and a beta of 0.80. Zeltiq Aesthetics has a 12-month low of $18.41 and a 12-month high of $40.98. The company has a 50-day moving average price of $37.50 and a 200-day moving average price of $30.52.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/21/zeltiq-aesthetics-inc-zltq-price-target-increased-to-52-00-by-analysts-at-stifel-nicolaus.html

Zeltiq Aesthetics (NASDAQ:ZLTQ) last announced its quarterly earnings data on Monday, August 8th. The company reported ($0.12) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.05) by $0.07. The firm earned $89.50 million during the quarter, compared to analyst estimates of $79.68 million. Zeltiq Aesthetics had a net margin of 9.54% and a negative return on equity of 9.90%. Zeltiq Aesthetics’s revenue for the quarter was up 38.9% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.03 EPS. On average, analysts predict that Zeltiq Aesthetics will post ($0.13) earnings per share for the current year.

In other Zeltiq Aesthetics news, Director Andrew N. Schiff sold 500,000 shares of Zeltiq Aesthetics stock in a transaction that occurred on Thursday, August 11th. The shares were sold at an average price of $36.39, for a total value of $18,195,000.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Mark J. Foley sold 10,000 shares of Zeltiq Aesthetics stock in a transaction that occurred on Wednesday, July 13th. The stock was sold at an average price of $31.21, for a total transaction of $312,100.00. Following the completion of the sale, the chief executive officer now directly owns 325,940 shares of the company’s stock, valued at $10,172,587.40. The disclosure for this sale can be found here. Insiders own 15.60% of the company’s stock.

A number of hedge funds have recently added to or reduced their stakes in ZLTQ. PineBridge Investments L.P. boosted its stake in Zeltiq Aesthetics by 4.9% in the second quarter. PineBridge Investments L.P. now owns 4,103 shares of the company’s stock valued at $112,000 after buying an additional 193 shares during the last quarter. Teacher Retirement System of Texas raised its position in shares of Zeltiq Aesthetics by 26.9% in the second quarter. Teacher Retirement System of Texas now owns 4,884 shares of the company’s stock worth $133,000 after buying an additional 1,036 shares during the period. Legal & General Group Plc raised its position in shares of Zeltiq Aesthetics by 1.7% in the first quarter. Legal & General Group Plc now owns 4,963 shares of the company’s stock worth $134,000 after buying an additional 83 shares during the period. Mason Street Advisors LLC bought a new position in shares of Zeltiq Aesthetics during the second quarter worth $173,000. Finally, Calamos Wealth Management LLC bought a new position in shares of Zeltiq Aesthetics during the second quarter worth $200,000.

About Zeltiq Aesthetics

ZELTIQ Aesthetics, Inc is a medical technology company. The Company focuses on developing and commercializing products utilizing its controlled-cooling technology platform. Its product, the CoolSculpting System, is designed to reduce stubborn fat bulges. It sell the CoolSculpting system primarily to dermatologists, plastic surgeons, aesthetic specialists, and obstetrics and gynecology physicians.

5 Day Chart for NASDAQ:ZLTQ

Receive News & Ratings for Zeltiq Aesthetics Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zeltiq Aesthetics Inc. and related companies with MarketBeat.com's FREE daily email newsletter.